A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection
Trial details
- Registry ID
- NCT04781647
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Vebicorvir
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionNCT04781647 | Assembly Biosciences | Phase 2 | Terminated | 2022-12-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |